Summary
It’s easy to think of financing approval rates as a patient-convenience issue. They’re really a margin issue. Every declined application is a treatment plan at risk — and a meaningful share of declined patients never start care at all.
Run a dental practice long enough and you learn an uncomfortable truth: production and profit are not the same thing. A practice can post record production one quarter and still watch its margin shrink — because overhead, declined treatment plans, and the hidden cost of the wrong financing partner quietly eat the difference between what you produce and what you keep.
For office managers, that gap is the whole job. You don’t control the clinical work, but you do control most of the levers that decide how much of each produced dollar actually reaches the bottom line. This guide breaks down what a healthy dental practice profit margin looks like in 2026, the costs that quietly erode it, and the specific levers you can pull to grow take-home profit — starting with the one almost no one puts on the P&L.
According to the 2026 State of Dental by Sunbit report — a survey of more than 4,400 practices — just over half (53%) reported higher profitability year over year, while a quarter saw flat results and another quarter saw declines. The gap between those groups wasn’t luck. It tracked closely with two things: how practices handle case acceptance, and how they handle the economics of patient financing.
What counts as a healthy dental practice profit margin?
Before you can improve a number, everyone on the team needs to mean the same thing by it. Four terms do most of the work:
- Production — the dollar value of treatment delivered.
- Collections — what you actually bank.
- Overhead — everything it costs to keep the doors open.
- Profit margin — what’s left for the owner after overhead, usually expressed as a percentage of collections.
Industry benchmarks generally place overhead in the 60–75% range, which leaves a profit margin somewhere around 25–40% before owner compensation — though that varies heavily by specialty, location, payer mix, and how the practice is structured. A high-volume general practice in a low-cost market looks very different from a specialty practice in a major metro.
Rather than chasing a single “right” number, the more useful habit is to track your own margin trend quarter over quarter and attack the line items you actually control. A practice moving its margin from 28% to 32% over a year is winning, regardless of where the industry average sits. The benchmark that matters most is your own last quarter.
The four levers office managers actually control
Most of what determines your margin comes down to four levers. The first two are familiar. The second two are where the quiet money lives.
- Case acceptance — the share of presented treatment that patients say yes to. This is the single biggest swing factor in production, and the one most influenced by how, and when, you present payment options.
- Overhead — supply costs, labor, occupancy, software, and the often-overlooked cost of your merchant and financing fees.
- Accounts receivable — money you’ve earned but haven’t collected. Every dollar aging in A/R is a dollar not working for you.
- Financing economics — not just whether you offer financing, but what each approved case actually nets your practice after fees.
Improve any one of these and your margin moves. Improve them together and the effect compounds, because they reinforce each other: better case acceptance fills the schedule, broader financing approvals keep those accepted cases alive, faster funding shrinks A/R, and lower financing fees protect the profit on every case that starts.
The hidden cost of “free” 0% APR financing
Here’s the lever almost no one puts on the P&L. When a patient financing product advertises 0% APR, that promotional interest is not free. It is typically subsidized by a higher merchant fee charged back to the practice. The patient sees 0%. The practice absorbs the cost — on every financed case, every month.
That cost is easy to miss because of where it lives. It doesn’t show up as a tidy line on your income statement; it’s buried inside transaction-level merchant statements that few practices reconcile case by case. Complex rate sheets make it worse — when fees vary by credit tier, term length, and which promotion the patient selected, the true cost per case becomes nearly impossible to forecast in advance.
Multiply even a modest fee differential across every financed case in a year and it becomes a real, recurring line item — frequently one of the largest unmanaged variable costs in the practice. The first step to protecting your margin isn’t to eliminate financing; it’s to surface what financing actually costs you, so you can manage it like any other expense.
Quick framing for your team
Two questions decide how much profit financing leaves you:
- How many patients get approved? (Declines mean lost production.)
- What does the practice pay per approved case? (Higher merchant fees mean lower take-home.)
A profit engine maximizes the first while minimizing the second.
Approvals are a margin lever, not just an access tool
It’s easy to think of financing approval rates as a patient-convenience issue. They’re really a margin issue. Every declined application is a treatment plan at risk — and a meaningful share of declined patients never start care at all.
Consider the math. If a financing partner approves only 60% of applicants, four in ten patients who needed a payment option just hit a wall. Some will find another way to pay. Many won’t. That’s production your team already earned — through the exam, the diagnosis, the case presentation — evaporating at the very last step.
Broader approvals keep more of that presented treatment alive. Sunbit approves 87% of applicants, including patients above a 500 credit score that prime-only lenders routinely decline, with no hard credit check.* The point isn’t the headline number on its own — it’s that approval rate sits directly upstream of production, and therefore upstream of margin. A higher approval rate widens the gate that every accepted case has to pass through before it becomes revenue.
Putting it together: the Profit Engine view
The practices that grow margin treat financing as a profit system, not a courtesy at the front desk. The logic is simple: more approvals expand the top of your production funnel, and lower, simpler pricing protects the bottom. More approvals plus lower pricing equals more take-home profit per case.
The State of Dental data bears this out. Sunbit-partnered practices saw profitability rise year over year at a rate of 59%, compared with 45% of non-Sunbit practices — a 14-point gap. Case acceptance rose for 61% of Sunbit practices versus 45% of others. These are the practices that stopped treating financing as a reactive tool for price objections and started operationalizing it as a lever for growth.
That shift — from courtesy to system — is the difference between a practice that merely offers financing and one that runs on it. The rest of this series breaks down each lever in turn, so you can build the system piece by piece:
- How to Calculate and Lower Your Dental Practice Overhead — including how to itemize the financing fees hiding in your overhead.
- How Patient Financing Impacts Your Dental Practice Cash Flow — and the “net deposit per case” metric that determines take-home.
- How to Reduce Accounts Receivable With Third-Party Financing — turning aging balances into upfront deposits.
- What KPIs Should Dental Office Managers Track Monthly? — the two financing metrics most dashboards miss.
- How to Set Realistic Production Goals for Your Dental Practice — building goals that account for approvals.
Start with the lever you control today
You won’t move your profit margin by working harder on production alone. The fastest gains come from the levers managers already control: protecting the profit on every case, keeping accepted treatment from dying at the financing step, and refusing to let “free” 0% offers quietly raise your costs. Surface what financing actually costs you, measure your approval rate, and the margin follows.
See what financing economics look like with higher approvals and simpler pricing. Sunbit pairs an 87% approval rate with two simple pricing tiers — built to drive more treatment starts while leaving more profit in your practice. See how Sunbit compares →
*Subject to approval based on creditworthiness. Approval rate and credit-score threshold reflect Sunbit dental program performance and may vary. Loans are made by Transportation Alliance Bank Inc. dba TAB Bank, which determines qualifications for and terms of credit.